ASCO in Action

ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.

To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.

Tune in to the ASCO in Action podcast series for analysis and commentary on cancer policy and practice issues. The podcast is available through iTunes or Google Play.

Showing results for Advocacy

September 14, 2021

On September 9, the U.S. Department of Health Human Services (HHS) released a report titled, Comprehensive Plan for Addressing High Drug Prices: A Report in Response to the Executive Order on Competition in the American Economy. The report comes following president Biden’s July 2021 Executive Order 14036, “Promoting Competition in the American Economy” (the Competition Executive Order), which directed HHS to publish a report presenting principles of prescription drug pricing reform.

September 14, 2021

The Association for Clinical Oncology (ASCO) commented on provisions in the 2022 Medicare Physician Fee Schedule (MPFS) and Quality Payment Program (QPP) proposed rule that would impact cancer care for Medicare beneficiaries. The letter also offers perspective on CMS’ four-stage plan to transition CMS’ quality measurement enterprise to being fully digital by 2025 and how the agency can improve data collection and measurement to help advance health equity in the Medicare program.

September 14, 2021

This summer, members of the Association for Clinical Oncology (ASCO) continued to push forward oncology-focused advocacy priorities by meeting with their Member of Congress or congressional staff during the congressional recess, or district work period.

September 13, 2021

The Association for Clinical Oncology (the Association) launched the ASCO Patient-Centered Cancer Care Certification, a new pilot that certifies outpatient oncology group practices and health systems that meet a single set of comprehensive, expert-backed standards for patient-centered care delivery. The pilot is based on recently published oncology medical home standards (OMH) from the American Society of Clinical Oncology (an affiliate of the Association) and the Community Oncology Alliance (COA).

August 17, 2021

The American Society of Clinical Oncology and the Association for Clinical Oncology (collectively ASCO) released an in-depth analysis of the impact the 2022 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) proposed rules—as well as pending sequestration cuts—could have on cancer care beginning January 1, 2022. 

August 6, 2021

The Association for Clinical Oncology (ASCO) commends the Biden Administration for proposing to rescind the Most Favored Nation (MFN) model from consideration. ASCO has consistently opposed the ill-advised MFN model, as it would have had a devastating impact on people with cancer. 

August 3, 2021

The Centers for Medicare & Medicaid Services (CMS) released updates to the Inpatient Prospective Payment System (IPPS) for fiscal year (FY) 2022 final rule, including updates to Medicare payment policies and payment rates for most acute care hospitals.

August 2, 2021

The Association for Clinical Oncology (ASCO) is calling on Congress to continue their bipartisan support of federally funded research. Robust, sustained, and predictable funding growth for the National Institutes of Health (NIH) and the National Cancer Institute (NCI) baseline budgets are critical in advancing our nation’s work towards combating, and ultimately curing, diseases like cancer.

July 28, 2021

The Association for Clinical Oncology submitted comments to the CMS regarding provisions in a 2022 Notice of Benefit and Payment Parameters proposed rule on extended and special enrollment provisions for federally-facilitated health insurance exchanges and state-based exchanges on the federal platform.

July 26, 2021

With COVID-19 case counts rising amid the spread of the Delta variant, the Association for Clinical Oncology joined more than 50 health care professional societies and organizations that represent millions of workers throughout health and long-term care in calling for all health care employers to require their employees to be vaccinated against COVID-19.

July 20, 2021

The Association for Clinical Oncology (ASCO) along with other health care organizations sent a letter to U.S. Senate leadership to convey their opposition to an extension of mandatory Medicare sequestration as a pay-for in any infrastructure package. The letter urges lawmakers to reconsider the potential use of Medicare funds included in the bipartisan infrastructure framework.

July 19, 2021

The Centers for Medicare & Medicaid Services (CMS) released its 2022 Hospital Outpatient Prospective Payment System (OPPS) proposed rule. Specific provisions that would impact the cancer care community are included here. 

July 16, 2021

ASCO provided comments on a recently released 21st Century Cures 2.0 Act discussion draft and accompanying Advanced Research Projects Agency Health (ARPA-H) request for information (RFI).  

July 13, 2021

On July 13, 2021, the Centers for Medicare & Medicaid Services released its proposed rule for the 2022 Medicare Physician Fee Schedule and updates to the Quality Payment Program (QPP). The Association for Clinical Oncology (ASCO) is still analyzing the full proposal, but based on a preliminary analysis, key provisions for the cancer care community are included here. 

July 6, 2021

In addition to the Association for Clinical Oncology’s (ASCO) advocacy at the federal level in Washington, DC, ASCO is also at work in state capitals advocating for improved patient access to high-quality, equitable cancer care at the state level.

Pages